Krankenhaus Martha-Maria Halle-Doelau gGmbH; Klinik fuer Innere Medizin I
Halle (Saale), Germany
Hospital department in Halle, Saxony-Anhalt
Röntgenstraße 1, 06120 Halle (Saale)
About Krankenhaus Martha-Maria Halle-Doelau gGmbH; Klinik fuer Innere Medizin I
"Wenn Sie unter Erkrankungen der Lunge oder Bronchien leiden, mit Schlafstörungen oder Krebs leben, sind wir für Sie da. Dazu umfasst die Klinik für Innere Medizin II folgende Schwerpunktabteilungen: • Lungen- und Bronchialheilkunde • Beatmungsmedizin • Hämatologie und Onkologie • Schlafmedizin • Palliativmedizin In unserem MVZ (Medizinisches Versorgungszentrum) bieten wir Ihnen folgende Spezialsprechstunden an: • Pneumologische Spezialambulanz • Hämatologisch-onkologische Spezialambulanz Als KV-Ermächtigungsambulanz bieten wir Ihnen folgende Spezialsprechstunde an: • Spezialambulanz für Schlafmedizin"
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
3
Clinical Trials at Krankenhaus Martha-Maria Halle-Doelau gGmbH; Klinik fuer Innere Medizin I
During the past decade, Krankenhaus Martha-Maria Halle-Doelau gGmbH; Klinik fuer Innere Medizin I conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on
average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of the Effect of R1507 in Combination With Tarceva (Erlotinib) on Progression-Free Survival in Patients With Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC).
2008-11-10
2010-06-25
Terminated
171
A Study of Bevacizumab in Combination With Standard of Care Treatment in Participants With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC)
2011-06-25
2016-06-25
Completed
485
A Study of Tiragolumab in Combination With Atezolizumab Compared With Placebo in Combination With Atezolizumab in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1-Selected Non-Small Cell Lung Cancer
2020-03-04
2025-02-21
Recruiting
660
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Krankenhaus Martha-Maria Halle-Doelau gGmbH; Klinik fuer Innere Medizin I
According to Clinical.Site data, the most researched conditions in "Krankenhaus Martha-Maria Halle-Doelau gGmbH; Klinik fuer Innere Medizin I" are
"Non-Squamous Non-Small Cell Lung Cancer" (2 trials) and "Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Krankenhaus Martha-Maria Halle-Doelau gGmbH; Klinik fuer Innere Medizin I" in a lesser frequency.
Clinical Trials Intervention Types at Krankenhaus Martha-Maria Halle-Doelau gGmbH; Klinik fuer Innere Medizin I
Most popular intervention types in "Krankenhaus Martha-Maria Halle-Doelau gGmbH; Klinik fuer Innere Medizin I" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (1 trials), "Bevacizumab" (1 trials), "Docetaxel" (1 trials), "Erlotinib" (1 trials) and "Matching Placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Krankenhaus Martha-Maria Halle-Doelau gGmbH; Klinik fuer Innere Medizin I
The vast majority of trials in "Krankenhaus Martha-Maria Halle-Doelau gGmbH; Klinik fuer Innere Medizin I" are
3 trials for "All" genders.
Clinical Trials Status at Krankenhaus Martha-Maria Halle-Doelau gGmbH; Klinik fuer Innere Medizin I
Currently, there are NaN active trials in "Krankenhaus Martha-Maria Halle-Doelau gGmbH; Klinik fuer Innere Medizin I".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Krankenhaus Martha-Maria Halle-Doelau gGmbH; Klinik fuer Innere Medizin I,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Krankenhaus Martha-Maria Halle-Doelau gGmbH; Klinik fuer Innere Medizin I, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".